| abstract |
The invention relates to a new association based on at least one ligand having a selective activity for the VDR receptor and on a retinoid chosen from 6- [3- (1-adamantyl) -4-hydroxyphenyl] -2 acid. -naphthanoic, 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphtanoic acid, or one of their derivatives, the use in dermatology or in cosmetics of this association, more particularly intended for treat diseases with hyperproliferation of skin cells, such as psoriasis. |